Analyst Ratings for Guardant Health (GH)
GH Rating Summary
GH Price Target Summary
- Highest: $135.00 (TD Cowen)
- Lowest: $60.00 (Scotiabank)
- Average: $111.46
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$111.46 (+22.2%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
Avg. $ Target:
$111.46 (+22.2%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/17/2026 | Baird | Catherine Schulte | New Coverage | Outperform (N/A) |
120.00 (N/A) |
102.76 (91.20) |
-11.25% | Details |
| 1/5/2026 | Evercore ISI » Updated 2/20/2026 |
Vijay Kumar | Downgrade | In Line (Outperform) |
110.00 (105.00) |
101.74 (91.20) |
-10.36% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


